Advertisement

Abstract

A. Lowering BP (BP) with a combination of drugs that includes an angiotensinconverting enzyme (ACE) inhibitor is superior to using any other agents, even if the BP is close to, but not at, goal levels. B. Lowering BP with any combination of agents will reduce cardiovascular risk if the BP is at goal levels. C. Use of a diuretic/ß-blocker combination is the only therapy that has been shown in clinical trials to effectively reduce cardiovascular risk regardless of the BP achieved. D. Risk for cardiovascular events plateaus at BP levels above 180 mmHg. E. A J-shaped curve relative to the occurrence of cardiovascular events exists for BP-lowering in people under the age of 50 years.

Keywords

Continuous Positive Airway Pressure Correct Answer Primary Aldosteronism Pediatric Nephrology White Coat Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bakris GL (2001) A practical approach to achieving recommended BP goals in diabetic patients. Arch Intern Med 161:2662–2667CrossRefGoogle Scholar
  2. Douglas JG, Bakris GL, Epstien M, et al. (2003) Management of high BP in African Americans: Consensus statements of the hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163:525–541CrossRefPubMedGoogle Scholar
  3. Chobanian AV, Bakris GL, Black HR, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP. The JNC-7 Report. JAMA 289:2560–2571CrossRefPubMedGoogle Scholar
  4. Wright JT, Bakris GL, Greene T, et al. (2002) Effect of BP lowering and antihypertensive drug class on progression of hypertensive kidney disease.: results from the AASK trial. JAMA 288:2421–2431CrossRefPubMedGoogle Scholar
  5. Psaty BM, Smith NL, Heckbert SR, et al. (2002) Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA 287:1680–1689CrossRefPubMedGoogle Scholar
  6. The Diabetes Prevention Program (DDP): description of lifestyle intervention. Diabetes Care 25:2165–2171Google Scholar
  7. Sacks FM, Svetky LP, Vollmer WM, et al. (2001) Effects on BP of reduced dietary sodium and the Dietary Approaches to stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344:3–10Google Scholar
  8. Wright JT, Bakris GL, Greene T, et al. (2002) Effect of BP lowering and antihypertensive drug class on progression of hypertensive kidney disease.: results from the AASK trial. JAMA 288:2421–2431CrossRefPubMedGoogle Scholar
  9. Douglas JG, Bakris GL, Epstien M, et al. (2003) Management of high BP in African Americans: Consensus statements of the hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163:541–541Google Scholar
  10. Chobanian AV, Bakris GL, Black HR, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP. The JNC-7 Report. JAMA 289:2560–2571CrossRefPubMedGoogle Scholar
  11. Chobanian AV, Bakris GL, Black HR, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP. The JNC-7 Report. JAMA 289:2560–2571CrossRefPubMedGoogle Scholar
  12. Liu M, Takahashi H, Morita Y, et al. (2003) Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in hemodialysis patients. Nephrol Dial Transplant 18:563–569CrossRefPubMedGoogle Scholar
  13. Fletcher EC (2003) Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 26:15–19PubMedGoogle Scholar
  14. Richert A, Ansarian K, Baran AS (2002) Sleep apnea and hypertension: pathophysiology mechanisms. Semin Nephrol 22:71–77PubMedGoogle Scholar
  15. Chobanian AV, Bakris GL, Black HR, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP. The JNC-7 Report. JAMA 289:2560–2571CrossRefPubMedGoogle Scholar
  16. Mansoor GA, Frishman WH (2002) Comprehensive management of hypertensive emergencies and urgencies. Heart Dis 4:358–371CrossRefPubMedGoogle Scholar
  17. Elliot WJ (2001) Hypertensive emergencies. Crit Care Clin 17:435–451CrossRefGoogle Scholar
  18. Brown RD (2003) Treatment of hypertensive patients with cerebrovascular disease. In; Izzo J and Black HR (eds): Hypertension Primer. Lippincott, Williams and Wilkins Dallas, pp.476–477Google Scholar
  19. Chobanian AV, Bakris GL, Black HR, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP. The JNC-7 Report. JAMA 289:2560–2571CrossRefPubMedGoogle Scholar
  20. Klag MJ, Whelton PK, Randall BL, et al. (1996) BP and end-stage renal disease in man. N Engl J Med 334:13–18CrossRefPubMedGoogle Scholar
  21. Tobian L (1997) Dietary sodium chloride and potassium have effects on the pathophysiology of hypertension in humans and animals. Am J Clin Nutr 65:606S–611SPubMedGoogle Scholar
  22. Schoenberg SO, Knopp MV, Londy F, et al. (2002) Morphologic and functional magnetic resonance imaging of renal artery stenosis: a multireader tricenter study. J Am Soc Nephrol 13:158–169PubMedGoogle Scholar
  23. Young WF, Jr (2002) Primary aldosteronism: management issues. Ann NY Acad Sci 970:61–76CrossRefPubMedGoogle Scholar
  24. Bur A, Herkner H, Vlcek M, et al. (2002) Classification of BP levels by ambulatory BP in hypertension. Hypertension 40:817–822CrossRefPubMedGoogle Scholar
  25. Logan AC, Perlikowski SM, Mente A (2001) Prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertension 19:2271–1177Google Scholar
  26. Gray BH, Olin JW, Childs MB (2002) Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vas Med 7:275–279CrossRefGoogle Scholar
  27. Leonardi-Bee J, Bath PM, Phillips SJ et al. (2002) BP and clinical outcomes in the International Stroke Trial. Stroke 33:1315–1320CrossRefPubMedGoogle Scholar
  28. Dimeny EM (2002) Cardiovascular disease after renal transplantation. Kidney Int 61:S78–S84CrossRefGoogle Scholar
  29. Bakris GL, Gaxiola E, Messerli FH (2003) Clinical outcomes in the diabetes cohort of the INVEST. Hypertension 44:637CrossRefGoogle Scholar
  30. Sacks FM, Svetkey LP, Vollmer WM, et al. (2001) Effects on BP of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-sodium Collaborative Research Group. N Engl J Med 344:3–10CrossRefPubMedGoogle Scholar
  31. Barkis GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160:685–693CrossRefGoogle Scholar
  32. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43:1–290Google Scholar
  33. Bakris GL, Weir MR (2003) Achieving goal BP in patients with Type 2 diabetes: conventional versus fixed-dose combination approaches. J Clin Hypertens 5:202–209CrossRefGoogle Scholar
  34. Leonardi-Bee, Bath PM, Phillips SJ, et al. (2002) BP and clinical outcomes in the International Stroke Trial. Stroke 33:1315–1320CrossRefPubMedGoogle Scholar
  35. Mulatero P, Stowasser M, Loh KC (2004) Increased diagnosis of primary aldosteronism, including surgically correctable form, in centers from five continents. J Clin Endocrinol Metab 89:1045–1050CrossRefPubMedGoogle Scholar
  36. Ritz E, Benck U, Franek E, et al. (1998) Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 9:1798–1804PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Farahnak Assadi
    • 1
  1. 1.Rush University Medical CenterChicago

Personalised recommendations